Rescuing and utilizing anticancer Nothapodytes species: Integrated studies fromplant resources to natural medicines

References

[1] Chen G, Cai XH, Tang J, et al. Anticancer drugs imperil Asian tree species. Science. 2024; 385: 1173.

[2] Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2012; 132: 1133-1145.

[3] Zhang SW, Sun KX, Zheng RS, et al. Cancer incidence and mortality in China, 2015. J Nat Cancer Cent. 2021; 1: 2-11.

[4] Lippi G, Mattiuzzi C. Current cancer epidemiology. J Epidemiol Glob Health. 2019; 9: 217-222.

[5] Zafar A, Khan MJ, Abu J, Naeem A. Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy. Mol Biol Rep. 2024; 51: 219-233.

[6] Ke X, Shen LS. Molecular targeted therapy of cancer: the progress and future prospect. Front Lab Med. 2017; 1: 69-75.

[7] Chau CH, Steeg PS, Figg WD. Antibody–drug conjugates for cancer. Lancet. 2019; 394: 793-804.

[8] Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012; 75: 311-335.

[9] Cragg GM, Pezzuto JM. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med Princ Pract. 2016; 25: 41-59.

[10] Kamle M, Pandhi S, Mishra S, et al. Camptothecin and its derivatives: advancements, mechanisms and clinical potential in cancer therapy. Med Oncol. 2024; 41: 263-281.

[11] Wang XZ, Zhuang YM, Wang YK, et al. The recent developments of camptothecin and its derivatives as potential anti-tumor agents. Eur J Med Chem. 2023; 260: 115710-115724.

[12] Weng WN, Meng T, Zhao QQ, et al. Antibody–exatecan conjugates with a novel self-immolative moiety overcome resistance in colon and lung cancer. Cancer Discov. 2023; 13: 950-973.

[13] Cao S, Kingston DGI. Biodiversity conservation and drug discovery: can they be combined? The Suriname and Madagascar experiences. Pharm Biol. 2009; 47: 809-823.

[14] Chen Y, Huang JP, Wang YJ, et al. Identification and characterization of camptothecin tailoring enzymes in Nothapodytes tomentosa. J Integr Plant Biol. 2024; 66: 1158-1169.

[15] Banadka A, Narasimha SW, Dandin VS, et al. Biotechnological approaches for the production of camptothecin. Appl Microbiol Biot. 2024; 108: 382-402.

[16] Helson JE, Capson TL, Johns T, et al. Ecological and evolutionary bioprospecting: using aposematic insects as guides to rainforest plants active against disease. Front Ecol Environ. 2008; 7: 130-134.

[17] Wender PA, Verma VA, Paxton TJ, Pillow TH. Function-oriented synthesis, step economy, and drug design. Acc Chem Res. 2008; 41: 40-49.

[18] Hattum HV, Herbert W. Biology-oriented synthesis: harnessing the power of evolution. J Am Chem Soc. 2014; 136: 11853-11859.

[19] Zhang X, Ang ECX, Yang Z, et al. Synthesis of chiral sulfinate esters by asymmetric condensation. Nature. 2022; 604: 298-303.

[20] Zhou YF, Yan BC, Yang Q, et al. Harnessing natural products by a pharmacophore-oriented semisynthesis approach for the discovery of potential anti-SARS-CoV-2 agents. Angew Chem Int Ed. 2022; 61: e202201684-e202201693.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.